Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106187982A reveals green ionic liquid catalysis for high-purity xanthenedione. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel reduction method for dexpramipexole dihydrochloride. High purity, mild conditions, cost-effective API manufacturing solution.
Patent CN1019300B reveals a direct acylation method for 7-amino-cephalosporins using acid salts, offering superior purity and cost efficiency for pharmaceutical manufacturers.
Patent CN1019300B reveals a novel acylation method for cephalosporins using acid addition salts, offering high purity and simplified processing for reliable pharmaceutical intermediates supply.
Novel bicomponent catalyst method for benzimidazoles. High purity, scalable process reducing costs for pharmaceutical intermediate manufacturing supply chains.
Patent CN1882600A reveals a novel route for enantiomerically enriched bisphospholane ligands, offering significant cost reduction in pharmaceutical intermediate manufacturing and improved supply chain reliability.
Patent CN1019300B reveals stable amine salt acylation for high-yield cephalosporins, offering cost-effective supply chain solutions.
Patent CN113548999A details a novel Pd-catalyzed route to 3-(2,3-butadienyl)oxindoles with high enantioselectivity, offering cost-effective solutions for antiviral drug development.
Patent CN102030658B reveals a safer route to 3-cyclopentamine using nitromethane cyclization, offering cost reduction and supply chain stability for pharmaceutical intermediates.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN111777477A details a mild visible-light method for synthesizing succinic acid derivatives and 3-arylpropionic acids using CO2, offering significant cost and safety advantages.
Patent CN112321425B details a novel two-step one-pot synthesis for methyl 4-(3-bromopropyl) benzoate, offering significant cost reduction and scalability for osteoporosis drug intermediates.
Patent CN107011134B reveals a streamlined lithiation-acetylation route for 2-fluoro-5-bromoacetophenone, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Discover the patented aqueous synthesis method for Cilostazol (CN1257902C). Achieve >99% purity with reduced environmental impact and optimized manufacturing costs.
Patent CN117051414A enables metal-free electrochemical synthesis. Delivers high-purity aryl sulfonyl fluoride with substantial cost reduction and supply chain reliability.
Patent CN85101840A details a novel stereoselective route for 16-phenoxy prostaglandin trienoic acid derivatives, offering improved crystallinity and supply chain reliability for pharmaceutical manufacturers.
Patent CN117343004A reveals mild catalyst-free route reducing cost and improving supply chain reliability for high-purity pharmaceutical intermediates globally.
Patent CN114277006B reveals a novel ADH for synthesizing chiral heterocyclic alcohols without organic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114057790B reveals high all-trans vitamin A phosphine salt synthesis. Enables cost reduction in vitamin manufacturing and reliable supply chain stability.
Patent CN102757356B details a cost-effective splitting process for D-HPG. Enhances supply chain reliability and reduces waste in API intermediate manufacturing significantly.